By expenditures
| Name | Title | Type |
|---|---|---|
| Rajee Rao | Chief Executive Officer | Auditee |
| Sabrina Preston | Partner | Auditee |
| B. Andrew Hall | EXECUTIVE DIRECTOR | Auditee |
| Sabrina Preston | Managing Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 367743 | 2024 | 2025-09-26 | Forvis Mazars LLP | $6.99M |
| 321407 | 2023 | 2024-09-26 | Forvis Mazars LLP | $6.98M |
| 51892 | 2022 | 2023-09-28 | Forvis LLP | $6.75M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 367743 | 2024 | 2025-09-26 | 1155461 | 2024-002 | Material Weakness | Yes | C |
| 367743 | 2024 | 2025-09-26 | 1155460 | 2024-002 | Material Weakness | Yes | C |
| 321407 | 2023 | 2024-09-26 | 1075168 | 2023-002 | Significant Deficiency | Yes | CL |
| 321407 | 2023 | 2024-09-26 | 1075167 | 2023-002 | Significant Deficiency | Yes | CL |
| 321407 | 2023 | 2024-09-26 | 1075166 | 2023-002 | Significant Deficiency | Yes | CL |
| 321407 | 2023 | 2024-09-26 | 1075165 | 2023-002 | Significant Deficiency | Yes | CL |
| 321407 | 2023 | 2024-09-26 | 1075164 | 2023-002 | Significant Deficiency | Yes | CL |
| 321407 | 2023 | 2024-09-26 | 1075163 | 2023-002 | Significant Deficiency | Yes | CL |
| 321407 | 2023 | 2024-09-26 | 1075162 | 2023-002 | Significant Deficiency | Yes | CL |
| 321407 | 2023 | 2024-09-26 | 498726 | 2023-002 | Significant Deficiency | Yes | CL |
| 321407 | 2023 | 2024-09-26 | 498725 | 2023-002 | Significant Deficiency | Yes | CL |
| 321407 | 2023 | 2024-09-26 | 498724 | 2023-002 | Significant Deficiency | Yes | CL |
| 321407 | 2023 | 2024-09-26 | 498723 | 2023-002 | Significant Deficiency | Yes | CL |
| 321407 | 2023 | 2024-09-26 | 498722 | 2023-002 | Significant Deficiency | Yes | CL |
| 321407 | 2023 | 2024-09-26 | 498721 | 2023-002 | Significant Deficiency | Yes | CL |
| 321407 | 2023 | 2024-09-26 | 498720 | 2023-002 | Significant Deficiency | Yes | CL |
| 51892 | 2022 | 2023-09-28 | 622924 | 2022-002 | Significant Deficiency | - | CL |
| 51892 | 2022 | 2023-09-28 | 622923 | 2022-002 | Significant Deficiency | - | CL |
| 51892 | 2022 | 2023-09-28 | 622922 | 2022-002 | Significant Deficiency | - | CL |
| 51892 | 2022 | 2023-09-28 | 46482 | 2022-002 | Significant Deficiency | - | CL |
| 51892 | 2022 | 2023-09-28 | 46481 | 2022-002 | Significant Deficiency | - | CL |
| 51892 | 2022 | 2023-09-28 | 46480 | 2022-002 | Significant Deficiency | - | CL |